EMS-CHEMIE (EMSN) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 Apr, 2026Executive summary
Sales volumes and operating income (EBIT) increased year-over-year, with improved profitability despite a challenging geopolitical environment and a strong Swiss Franc dampening net sales growth.
Strong demand for energy and cost-saving system solutions, with successful new business and innovation driving results.
No business relationships in the Middle East; global uncertainty and higher input costs are being managed through price increases.
Financial highlights
Net sales for Q1 2026 were CHF 487 million, down 6.6% year-over-year due to currency effects.
Operating income (EBIT) and sales volumes rose above the previous year, with margins considerably improved.
Outlook and guidance
Net sales for 2026 expected to remain below the previous year due to currency effects.
Net operating income (EBIT) is projected to be slightly above the previous year.
Geopolitical risks, trade conflicts, and higher energy/raw material costs expected to persist, impacting global supply chains and economic sentiment.
Latest events from EMS-CHEMIE
- EBIT rose 5.2% to CHF 567 million, with improved margins and strong cash flow in 2025.EMSN
Q4 20256 Feb 2026 - Net sales fell 6.2% but profitability rose, with EBIT expected slightly above last year.EMSN
Q3 202520 Oct 2025 - EBIT rose 1.4% and margins improved, despite lower sales and a challenging global environment.EMSN
Q2 202511 Jul 2025 - Net sales declined but EBIT improved, driven by new business and segment expansion.EMSN
Q3 202413 Jun 2025 - EBIT and EBITDA rose despite lower sales, with strong margins and cautious 2024 outlook.EMSN
H1 202413 Jun 2025 - Q1 2025 sales fell 4.3%, but innovation and new business kept EMS Group's EBIT outlook positive.EMSN
Q1 20256 Jun 2025 - EBIT up 9.5% and dividend raised, with innovation driving growth despite currency headwinds.EMSN
Q4 20245 Jun 2025